Atlas Trials

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Clinical trial NCT05047783 · UNKNOWN

Trial details

NCT number
NCT05047783
Sponsor
AB Science
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
Start date
2021-11-23
Primary completion
2023-12-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.